Your browser doesn't support javascript.
loading
Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients.
Zaloumis, Sophie G; Whyte, Jason M; Tarning, Joel; Krishna, Sanjeev; McCaw, James M; Cao, Pengxing; White, Michael T; Dini, Saber; Fowkes, Freya J I; Maude, Richard J; Kremsner, Peter; Dondorp, Arjen; Price, Ric N; White, Nicholas J; Simpson, Julie A.
Afiliação
  • Zaloumis SG; Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia sophiez@unimelb.edu.au.
  • Whyte JM; Centre of Excellence for Biosecurity Risk Analysis, School of BioSciences, University of Melbourne, Melbourne, Australia.
  • Tarning J; Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers, School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia.
  • Krishna S; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • McCaw JM; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Cao P; Institute for Infection and Immunity, St. George's Hospital, University of London, London, United Kingdom.
  • White MT; Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Dini S; School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia.
  • Fowkes FJI; School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia.
  • Maude RJ; Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
  • Kremsner P; Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Dondorp A; Centre for Epidemiology & Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Price RN; Disease Elimination Program, Burnet Institute, Melbourne, Australia.
  • White NJ; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Simpson JA; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Antimicrob Agents Chemother ; 65(6)2021 05 18.
Article em En | MEDLINE | ID: mdl-33685888
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Malária Falciparum / Malária / Antimaláricos Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans País/Região como assunto: Africa / Asia Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND / 4_TD / 7_ODS3_muertes_prevenibles_nacidos_ninos Base de dados: MEDLINE Assunto principal: Malária Falciparum / Malária / Antimaláricos Tipo de estudo: Prognostic_studies Limite: Adult / Child / Humans País/Região como assunto: Africa / Asia Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article